Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
611.05B
Market cap611.05B
Price-Earnings ratio
29.80
Price-Earnings ratio29.80
Dividend yield
2.03%
Dividend yield2.03%
Average volume
7.27M
Average volume7.27M
High today
$250.25
High today$250.25
Low today
$248.47
Low today$248.47
Open price
$255.46
Open price$255.46
Volume
114.86K
Volume114.86K
52 Week high
$269.43
52 Week high$269.43
52 Week low
$154.80
52 Week low$154.80

Stock Snapshot

With a market cap of 611.05B, Johnson & Johnson(JNJ) trades at $248.85. The stock has a price-to-earnings ratio of 29.80 and currently yields dividends of 2.03%.

As of 2026-07-15, Johnson & Johnson(JNJ) stock has fluctuated between $248.47 and $250.25. The current price stands at $248.85, placing the stock +0.2% above today's low and -0.6% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 114.86K, compared to an average daily volume of 7.27M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

JNJ News

CNBC 17m
J&J quarterly earnings beat Wall Street estimates on strength of medicines unit - CNBC

...

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit - CNBC
Seeking Alpha 29m
J&J falls premarket despite Q2 beats, updated guidance

Johnson & Johnson (JNJ) is down ~1.8% in premarket trading Wednesday despite posting Q2 financial results that beat on both lines and revising its 2026 revenue...

J&J falls premarket despite Q2 beats, updated guidance
The Wall Street Journal 1h
Johnson & Johnson Bumps Up Guidance as Sales Rise

Johnson & Johnson raised its forecast for the year after recording higher sales. Yves Herman / Reuters Johnson & Johnson JNJ -1.52 %decrease; down pointing tri...

Johnson & Johnson Bumps Up Guidance as Sales Rise

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

TipRanks 1h
Genmab reports Q2 net sales of Darzalex $4.207B

Genmab (GMAB) announced that worldwide net trade sales of DARZALEX, or daratumumab, including sales of the subcutaneous, or SC, product, daratumumab and hyaluro...

Nasdaq 1h
Johnson & Johnson Bottom Line Declines In Q2

(RTTNews) - Johnson & Johnson (JNJ) announced a profit for second quarter that Drops, from last year The company's bottom line came in at $5.534 billion, or $2...

Johnson & Johnson Bottom Line Declines In Q2
TipRanks 1h
Johnson & Johnson reports Q2 adjusted EPS $2.90, consensus $2.85

Reports Q2 revenue $25.31B, consensus $25.06B. “Johnson & Johnson delivered strong second-quarter results, demonstrating the power of our innovation, the depth...

24/7 Wall St. 2h
What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield

What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield By Drew Wood Published Jul 15, 6:17AM EDT Quick Read Generating $96,000 annually in...

What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield
24/7 Wall St. 20h
A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets

A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets By Drew Wood Published Jul 14, 12:12PM EDT Quick Read How assets are arra...

A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets
Benzinga 20h
Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 – ‘Continue Their Winning Ways’

Johnson & Johnson Q2 Earnings Estimates Analysts expect Johnson & Johnson to report second-quarter revenue of $25.05 billion, up from $23.74 billion in last yea...

Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 – ‘Continue Their Winning Ways’
24/7 Wall St. 22h
A Dividend Portfolio That Can Cover the Cost of Living in San Francisco

A Dividend Portfolio That Can Cover the Cost of Living in San Francisco By Drew Wood Published Jul 14, 10:03AM EDT Quick Read Replacing San Francisco's ~$135,...

A Dividend Portfolio That Can Cover the Cost of Living in San Francisco

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.